ClinicalTrials.gg
RecruitingNCT07896954Updated Oct 27, 2026

A Comparison of Heart Rate Variability Biofeedback, Mindfulness, and Psychoeducation-based Interventions on Clinical Recovery Outcomes in Patients Undergoing Total Knee Arthroplasty

An interventional study of Heart rate variability biofeedback and Mindfulness in Pain (Knee), Pain and Anxiety and TKA, sponsored by Chang Gung Memorial Hospital. Recruiting at 2 sites in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jan 2026, registered Oct 2026).
  • Started Jan 2026; still recruiting 9 months later.
Updated Oct 27, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to compare the effects of heart rate variability biofeedback (HRVB), mindfulness meditation, and psychological education in patients undergoing total knee arthroplasty (TKA). Patients waiting for TKA often experience anxiety, pain, and sleep problems before surgery. These factors may affect recovery after surgery. HRVB and mindfulness have been used to reduce stress and anxiety in different patient groups, but few studies have directly compared these approaches in patients undergoing TKA.

The main questions this study aims to answer are:

  • Does HRVB improve postoperative recovery, including pain, sleep quality, quality of life, and knee function, compared with mindfulness meditation and psychological education?
  • Do HRVB and mindfulness meditation reduce preoperative anxiety more effectively than psychological education?
  • Are changes in heart rate variability and EEG measures related to recovery outcomes after surgery?

Researchers will compare HRVB, mindfulness meditation, and psychological education to evaluate their effects on anxiety reduction and postoperative recovery.

Participants will:

  • Be randomly assigned to one of three groups: HRVB, mindfulness meditation, or psychological education.
  • Receive one 15-minute intervention session before surgery.
  • Continue home-based practice during the first 2 weeks after surgery while following routine rehabilitation exercises.
  • Complete assessments before surgery and at 2, 6, and 12 weeks after surgery.

The assessments will include measures of anxiety, pain, sleep quality, quality of life, knee function, heart rate variability, and EEG activity.

02

Conditions studied

  • Pain (Knee)
  • Pain and Anxiety
  • TKA
03

In context

Pain

2,461 studies on the registry are indexed under Pain; 942 are open to participants now.

This study's planned enrollment of 120 is above the median of 70 across 2,102 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,094 studies on the registry; 239 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

patients undergoing total knee arthroplasty (TKA) with

  1. pain ≥3 months and ≥3 days per week
  2. pain intensity ≥40 (VAS scale from 0 no pain to 100 very painful)
  3. willingness to participate in this trial before surgery, follow postoperative home-based breathing training, and not receive other related interventions
  4. surgical indication based on orthopedic physician's opinion

Exclusion criteria

Exclusion Criteria:

  1. history of surgery on the same knee
  2. osteoporotic fractures or rheumatologic diseases
  3. chronic widespread pain
  4. neurological disease (i.e., stroke, Parkinson's disease, etc.)
  5. psychiatric disease (i.e., dementia, depression, schizophrenia, etc.)
  6. cancer
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    HRV biofeedback

    A single 15-minute preoperative HRV biofeedback session (five 3-minute stages of resonance-frequency breathing), followed by daily home-based HRV biofeedback practice with a wearable device during postoperative weeks 0-2, in addition to routine home rehabilitation exercises.

    Behavioral: Heart rate variability biofeedback

  • Active comparator
    Mindfulness-based breathing

    A single 15-minute preoperative mindfulness-based breathing session, followed by home practice with a recorded mindfulness guide during postoperative weeks 0-2, in addition to routine home rehabilitation exercises.

    Behavioral: Mindfulness

  • Active comparator
    Cognitive-Behavioral Pain Psycho-Education

    A single 15-minute preoperative pain psychoeducation session, followed by reviewing the course content at home as needed during postoperative weeks 0-2, in addition to routine home rehabilitation exercises.

    Behavioral: psychoeducation

Interventions

  • BehavioralHeart rate variability biofeedback

    The 15-minute preoperative HRV biofeedback session consists of five 3-minute stages of resonance-frequency breathing (generally 4.5 to 6.5 breaths per minute) guided by an external pacer. During postoperative weeks 0-2, participants practice HRV biofeedback daily at home using a remote wearable HRV biofeedback device.

  • BehavioralMindfulness

    The 15-minute preoperative mindfulness session is a scripted exercise recorded by a professional mindfulness instructor. It guides participants to attend to the breath and bodily sensations and to accept wandering thoughts, negative emotions and pain in a non-judgmental fashion. During postoperative weeks 0-2, participants continue practice at home using the recording.

  • Behavioralpsychoeducation

    The 15-minute preoperative psychoeducation session provides pain education and discusses behavioral coping strategies for pain management. During postoperative weeks 0-2, participants review the course content at home as needed.

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale change

    Subjective post-surgical pain. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

  2. Pittsburgh Sleep Quality Index (PSQI)

    The global PSQI score is then calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

  3. Hospital Anxiety and Depression Scale (HADS)

    HADS measures anxiety and depression in the medical setting. Higher scores indicate greater anxiety and depression.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

  4. EuroQol-5D questionnaire (EQ-5D)

    EQ-5D-5L is a standardized measure of health-related quality of life. The higher transformed scores, the better HRQoL.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

Secondary outcomes

  1. Visual Analogue Scale for Anxiety (VAS-A)

    Subjective anxiety rated on a 100-mm line from 0 (no anxiety) to 100 (worst imaginable anxiety). Higher scores indicate greater anxiety.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

  2. Heart rate variability (HRV)

    Time-domain (SDNN, RMSSD) and frequency-domain (LF, HF power) HRV indices derived from short-term ECG/PPG recordings. Higher RMSSD and HF indicate greater parasympathetic activity.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

  3. Knee injury and Osteoarthritis Outcome Score (KOOS)

    Patient-reported knee function across five subscales (pain, symptoms, activities of daily living, sport/recreation, knee-related quality of life), each scored 0-100. Higher scores indicate better function.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

  4. Knee range of motion (ROM)

    Active knee flexion and extension measured in degrees with a goniometer. Larger flexion range indicates better knee mobility.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

  5. Manual muscle testing (MMT) of hamstrings and quadriceps

    Hamstring and quadriceps strength graded on the 0-5 manual muscle testing scale. Higher grades indicate greater muscle strength.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

  6. Timed Up and Go Test (TUG)

    Time (seconds) to rise from a chair, walk 3 meters, turn, walk back and sit down. Shorter times indicate better functional mobility.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

  7. 2-Minute Walk Test (2MWT)

    Distance (meters) walked in 2 minutes. Longer distances indicate better walking capacity.

    Time frame: Baseline (preoperative) and at 2, 6, and 12 weeks after surgery

  8. Tampa Scale for Kinesiophobia (TSK-11)

    11-item questionnaire assessing fear of movement and re-injury, total score 11-44. Higher scores indicate greater kinesiophobia. Assessed as a predictor of postoperative recovery.

    Time frame: Baseline (preoperative)

  9. Pain Catastrophizing Scale (PCS)

    13-item questionnaire assessing rumination, magnification and helplessness about pain, total score 0-52. Higher scores indicate greater pain catastrophizing. Assessed as a predictor of postoperative recovery.

    Time frame: Baseline (preoperative)

  10. State-Trait Anxiety Inventory (STAI-S/T)

    Two 20-item subscales measuring state and trait anxiety, each scored 20-80. Higher scores indicate greater anxiety.

    Time frame: Baseline (preoperative) and 12 weeks after surgery

  11. Beck Depression Inventory (BDI)

    21-item self-report measure of depressive symptoms, total score 0-63. Higher scores indicate more severe depressive symptoms.

    Time frame: Baseline (preoperative) and 12 weeks after surgery

07

Study locations

2 of 2 sites recruiting
  • Chang Gung Memorial Hospital, Linkou
    Taoyuan, 333, Taiwan
    Recruiting
  • Chang Gung Memorial Hospital
    Taoyuan, 333, Taiwan
    • ChihHao Chiu, PhD, MD · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared because participants did not consent to data sharing beyond the research team, as approved by the Institutional Review Board of Chang Gung Medical Foundation. De-identified data may be made available from the principal investigator upon reasonable request and with IRB approval.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jul 2027, 18 months after the start.

Of 1,253 non-industry interventional studies with no phase under Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 29. This study's planned 18 months is above that.

Counting every sponsor, half of 1,276 studies reached it within 11 months; a quarter within 5 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 20, 2026
First posted
Oct 27, 2026
StartActual
Jan 21, 2026
Primary completionEst.
Jul 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07896954
Responsible party
Poyu Chen (Assistant Professor, Chang Gung Memorial Hospital) — Principal investigator
First posted
Oct 27, 2026
Start date
Jan 21, 2026
Primary completion
Jul 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 27, 2026

Study contacts

Poyu Chen, PhD
Contact
poyuchen@mail.cgu.edu.tw
+886-3-211-8800 ext. 5449
Chih-Hao Chiu, PhD, MD
study chair · Chang Gung MH
Poyu Chen, PhD
principal investigator · Chang Gung University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion